These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15034795)

  • 1. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy.
    Yu JL; May L; Klement P; Weitz JI; Rak J
    Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
    Rak J; Milsom C; May L; Klement P; Yu J
    Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse roles of tissue factor-expressing cell subsets in tumor progression.
    Milsom C; Yu J; May L; Magnus N; Rak J
    Semin Thromb Hemost; 2008 Mar; 34(2):170-81. PubMed ID: 18645922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.
    Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B
    Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor and tumor: clinical and laboratory aspects.
    Förster Y; Meye A; Albrecht S; Schwenzer B
    Clin Chim Acta; 2006 Feb; 364(1-2):12-21. PubMed ID: 16139825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
    Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
    Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor and cancer stem cells: is there a linkage?
    Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor and cancer.
    Milsom C; Rak J
    Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor in tumour progression.
    Rak J; Milsom C; Magnus N; Yu J
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):71-83. PubMed ID: 19285274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo.
    Bluff JE; Amarzguioui M; Slattery J; Reed MW; Brown NJ; Staton CA
    Breast Cancer Res Treat; 2011 Aug; 128(3):691-701. PubMed ID: 20830515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tissue factor and angiogenesis-related genes by changes in cell shape.
    Milsom C; Rak J
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1267-75. PubMed ID: 16236262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
    López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
    Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.